Clear, engaging, and practical updates on clinical psychiatry.
Earn CME for listening to the podcast with a Podcast CME Subscription.
Listen for free here or using Apple Podcasts and Spotify.
Lurasidone (Latuda) has gone generic. Find out where this antipsychotic fits in bipolar disorder with updates from the 2023 International Bipolar Conference.
Do you see patients who have no motivation to do anything? Michael Posternak has a novel strategy for working with this depressive symptom during the medication visit in this special tribute to the late psychiatrist.
Almost 90% of older adults have experienced at least one traumatic event in their lifetime, yet posttraumatic stress disorder (PTSD) continues to be overlooked in older patients. Clinicians should routinely assess for symptoms of PTSD, as a missed diagnosis can lead to poor health outcomes including increased suicide risk. In this episode, we will shed some light on assessing and treating PTSD in the older patient.
Updates from the 2023 International Bipolar Conference, including new diagnostic tools for bipolar disorder. Stanford researchers propose a new subtype of depression.
Several psychiatric medications prolong the QTc interval and place patients at risk of the dreaded torsade de pointes. Some patients are particularly vulnerable to QTc prolongation: the elderly, patients with heart disease and electrolyte imbalances, and patients taking certain medications, like thioridazine and ziprasidone. In this podcast, we provide a step-by-step guide so that you can keep your patients safe from this cardiovascular side effect.
Stephen Stahl steps down from the industry-sponsored podium to remind us of 3 reasons to use an MAOI: Atypical depression, treatment-resistant depression, and social anxiety disorder.
Delirium is widespread among patients in ICUs and surgery units. In this podcast, we will review the workup and management of this common condition and give you tips to help prevent it in high-risk patients